Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses
ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]
HKUMed and CityU Scientists Discover Non-invasive Stimulation of the Eye for Depression and Dementia
A joint research team from Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) […]
EarlySign Announces Strategic Collaboration Agreement with Roche on AI Solution for Early Detection of Lung Cancer
Medial EarlySign (earlysign.com), a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced today […]
Unilabs Sweden Launches Subtle Medical's AI-powered Imaging Technology to Further Bolstering Patient Care
Unilabs, the leading diagnostic services provider, announced a partnership with Subtle Medical, a healthcare technology […]
Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets
Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]
Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs
Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, […]
ProteoNic Announces Licensing of Its Premium 2G UNic™ Technology Platform for Production of Biologics to Fyonibio
ProteoNic BV, a leading provider of premium vector technology and services for efficient production of […]
Mogrify and Astellas Announce Collaboration to Conduct Research on in Vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss
Mogrify Limited (CEO: Darrin M. Disley, Ph.D., “Mogrify®”), a biopharmaceutical company transforming the lives of […]
Implanet Announces a Commercial, Technological and Financial Partnership With Sanyou Medical, a Chinese Manufacturer of Medical Devices for Spine Surgery
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company […]
Swing Therapeutics Selects Curavit to Provide Virtual Trial Site Services for Novel Digital Therapeutic Study for Fibromyalgia
Curavit Clinical Research, a virtual contract research organization (VCRO), has been selected by digital therapeutics company, Swing […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more